Perspective Therapeutics (CATX) Non-Current Assets (2011 - 2026)

Perspective Therapeutics has disclosed Non-Current Assets across 16 years of filings, most recently posting $135.4 million for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $135.4 million, up 19.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $485.1 million (up 11.21% YoY), and the FY2025 annual result was $118.6 million, up 7.86% from the prior year.
• Non-Current Assets came in at $135.4 million for Q1 2026 at Perspective Therapeutics, up from $118.6 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $135.4 million in Q1 2026 to a low of $3.4 million in Q1 2022.
• The 5-year median for Non-Current Assets is $90.1 million (2024), against an average of $80.9 million.
• Across the five-year window, Non-Current Assets jumped 2504.44% in 2023 and declined 3.85% in 2025, its largest moves.
• Perspective Therapeutics' Non-Current Assets stood at $4.9 million in 2022, then jumped by 1562.31% to $81.1 million in 2023, then jumped by 35.64% to $109.9 million in 2024, then increased by 7.86% to $118.6 million in 2025, then gained by 14.2% to $135.4 million in 2026.
• The last three Non-Current Assets figures came in at $135.4 million (Q1 2026), $118.6 million (Q4 2025), and $116.3 million (Q3 2025), per Business Quant data.